Medtronic MiniMed Insulin Pump Lawsuits 2026: Retainer-Ring Failures, 2 New Cases & Who Can File

Problem Solved readers ask whether a faulty pump supports a lawsuit. The answer is yes, in the right case: Medtronic MiniMed lawsuits allege a defective retainer ring in 600-series pumps can cut off insulin or flood the body with it, causing coma or death, and two July 2026 cases revived the litigation.

MiniMed is Medtronic's line of insulin pumps that deliver continuous insulin through the day, plus extra doses when needed. Diabetic ketoacidosis (DKA) is a life-threatening condition in which too little insulin lets blood sugar climb until acids called ketones build up in the blood. Hypoglycemia is blood sugar falling so low it causes confusion, seizures, or unconsciousness.

  • 600-series: the MiniMed 630G and 670G pumps in the retainer-ring recall
  • October 2024: a separate Class I battery recall covering tens of thousands of pumps
  • July 2026: two new federal cases — a wrongful-death claim in Washington, a coma claim in Florida
  • May 2026: reports say the first MiniMed trial began in Los Angeles
  • July 2023: at least two federal judges ruled MiniMed claims preempted — binding only those cases

What the retainer-ring defect actually does

The core allegation concerns a small, clear plastic ring inside the MiniMed 630G and 670G pumps that locks the insulin cartridge into the reservoir compartment. When it breaks, loosens, or goes missing — sometimes from an ordinary drop — the cartridge can fail to seat properly, and the failure cuts both ways. If the reservoir stays partly connected while the infusion set is attached to the body, inserting it can trigger a rapid burst of insulin and severe hypoglycemia. If instead a gap opens, the pump cannot deliver its programmed dose, blood sugar climbs, and untreated hyperglycemia can spiral into ketoacidosis.

The recalls behind the lawsuits

The retainer-ring problem led to a major Class I recall of the 600-series pumps. Class I is the FDA's most serious recall category, used when a defect carries a reasonable probability of serious injury or death. Separately, in October 2024, the FDA announced another Class I recall of tens of thousands of MiniMed pumps over battery risks: after a drop or impact, the battery could deplete rapidly, leaving the pump unable to deliver insulin. A recall does not prove liability in any individual case, but the recalls document that the company and the regulator recognized the failure modes patients describe. If you received a recall letter, keep it.

The 2026 cases: two July filings and the May trial

Two July 2026 filings show the litigation is still moving. On July 6, 2026, a Washington man sued on behalf of his late father's estate, alleging that a defective retainer ring in a MiniMed 670G pump failed and caused his father's death from ketoacidosis; the case was removed to the Western District of Washington on June 29. On July 17, 2026, a Florida woman alleged that her MiniMed 780G pump stopped delivering insulin on June 12, 2022, despite proper maintenance and use as directed, leaving her with severe injuries and a diabetic coma; that case was removed to the Southern District of Florida on July 6. Reports also say the first MiniMed trial began in Los Angeles in May 2026.

The preemption hurdle every claimant must clear

Preemption is a legal doctrine under which federal approval of a medical device can block state-law injury claims. In July 2023, at least two federal judges ruled that MiniMed pump claims were preempted, but those rulings are a warning, not a verdict on every case: they bind only the cases before those judges and can be appealed. Whether preemption defeats a claim often turns on the specific device, the specific failure, and the claims pleaded, which is why an individual case review matters more here than in most device litigations. There is no multidistrict litigation (MDL) consolidating MiniMed injury claims, so cases proceed individually.

Who Benefits From This — and Who Does Not

These lawsuits can benefit people whose pump actually failed and caused harm: 600-series or 780G users hospitalized for ketoacidosis, a diabetic coma, or severe hypoglycemia after their pump stopped delivering insulin or delivered it in a burst, and families of patients who died after such a failure — the July 2026 Washington case is exactly that kind of claim. People who still have the pump, the recall letter, and records showing the failure — alarm logs, glucose and CGM readings, and the serial number — are in the strongest position, because the case turns on proving the device, not just the disease. For context, see our guides to the Exactech implant recalls and the DePuy hip implant litigation.

By contrast, this litigation does not benefit everyone who owns a recalled pump. A recall letter alone, without an injury caused by a device failure, rarely supports an injury claim. Nor does it help patients whose injuries came from diabetes itself, or from use contrary to the instructions, without evidence that the device malfunctioned. Time limits matter too: statutes of limitations run state by state.

What to preserve if your pump failed

Do not throw the pump away. Keep the device, its box and packaging, the recall letter, and any photos of alarms or error messages. Save glucose meter and CGM readings from the time of the event, pharmacy records showing which pump you used, and every medical record and bill tied to the hospitalization. Note the date, the symptoms, and what the pump displayed, while the memory is fresh. Most firms offer free evaluations and work on contingency — confirm that arrangement in writing before signing anything.

Frequently Asked Questions

Who benefits from a MiniMed insulin pump lawsuit?

People hospitalized for ketoacidosis, a diabetic coma, or severe hypoglycemia after their MiniMed pump failed — by stopping insulin or delivering it in a burst — and families of patients who died after such a failure. The strongest cases pair a recalled model with records proving the failure.

Who does not benefit, or likely cannot file?

People who owned a recalled pump but suffered no injury from a device failure, people whose injuries came from diabetes itself or misuse without device malfunction, and people whose filing deadline has passed. Preemption rulings may also bar some claims.

How do I start a MiniMed pump claim?

First, preserve the pump, its packaging, the recall letter, and your glucose and CGM readings. Second, gather the medical records and bills. Third, request a free case review and confirm the contingency fee arrangement in writing before signing.

Is there a MiniMed insulin pump settlement?

No global settlement has been announced for MiniMed injury claims, and the cases are proceeding individually rather than through an MDL. Compensation varies widely by case, and most settlements are confidential.

Do I have to stop using my pump to file a claim?

No. Filing a claim has nothing to do with your treatment, and stopping insulin without medical guidance is dangerous. Talk to your prescriber about your device and keep using prescribed therapy unless your doctor tells you otherwise.

See also our guides to the Da Vinci surgical robot cases, the Exactech implant recalls, and the DePuy hip implant litigation.

This article is general information about a legal development, not legal or medical advice. For advice about your own situation, consult a qualified attorney or your doctor.

Watch on YouTube

Problem Solved on YouTube